Literature DB >> 16534424

Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data.

Virginie Nerich1, Elisabeth Monnet, Arnaud Etienne, Samy Louafi, Cécile Ramée, Stéphane Rican, Alain Weill, Nathalie Vallier, Vincent Vanbockstael, Guy-Robert Auleley, Hubert Allemand, Franck Carbonnel.   

Abstract

BACKGROUND AND AIM: A north-south gradient in inflammatory bowel disease (IBD) incidence has been found in Europe and the United States. Its existence is inferred from comparisons of registries that cover only small portions of territories. Several studies suggest that IBD incidence in the north has reached a plateau, whereas in the south it has risen sharply. This evolution tends to reduce the north-south gradient, and it is uncertain whether it still exists. In France, patients with IBD are fully reimbursed for their health expenses by the national health insurance system, which is a potential source of data concerning the incidence of IBD at the national level. The aim of this study was to assess the geographical distribution of Crohn's disease (CD) and ulcerative colitis (UC) in France and to test the north-south gradient hypothesis.
METHODS: This study was conducted in metropolitan France and included patients to whom IBD reimbursement was newly attributed between January 1, 2000 and December 31, 2002. Data provided relate to age, sex, postcode area of residence, and IBD type. The mapping of geographical distribution of smoothed relative risks (RR) of CD and UC was carried out using a Bayesian approach, taking into account autocorrelation and population size in each département.
RESULTS: In the overall population, incidence rates were 8.2 for CD and 7.2 for UC per 100,000 inhabitants. A clear north-south gradient was shown for CD. Départements with the highest smoothed RR were located in the northern third of France. By contrast, the geographical distribution of smoothed RR of UC was homogeneous.
CONCLUSIONS: This study shows a north-south gradient in France for CD but not for UC.

Entities:  

Mesh:

Year:  2006        PMID: 16534424     DOI: 10.1097/01.MIB.0000206540.38834.8c

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  27 in total

Review 1.  Advances in epidemiology and diagnosis of inflammatory bowel diseases.

Authors:  Sobia Ali; Cyrus P Tamboli
Journal:  Curr Gastroenterol Rep       Date:  2008-12

Review 2.  Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?

Authors:  Cristina Saro Gismera; Beatriz Sicilia Aladrén
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

3.  Increasing ultraviolet light exposure is associated with reduced mortality from Clostridium difficile infection.

Authors:  Shail M Govani; Akbar K Waljee; Ryan W Stidham; Peter Dr Higgins
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

Review 4.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 5.  Linking vitamin d deficiency to inflammatory bowel disease.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Inflamm Bowel Dis       Date:  2013-09       Impact factor: 5.325

6.  Geographical variation and incidence of inflammatory bowel disease among US women.

Authors:  Hamed Khalili; Edward S Huang; Ashwin N Ananthakrishnan; Leslie Higuchi; James M Richter; Charles S Fuchs; Andrew T Chan
Journal:  Gut       Date:  2012-01-11       Impact factor: 23.059

Review 7.  Vitamin D and the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Berkeley N Limketkai; Matthew L Bechtold; Douglas L Nguyen
Journal:  Curr Gastroenterol Rep       Date:  2016-10

Review 8.  Epidemiology and clinical course of Crohn's disease: results from observational studies.

Authors:  Øistein Hovde; Bjørn A Moum
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

9.  cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation.

Authors:  Eric Albert; John Walker; Aducio Thiesen; Thomas Churchill; Karen Madsen
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease.

Authors:  Lars E Bartels; Søren P Jørgensen; Mia Bendix; Christian L Hvas; Jørgen Agnholt; Ralf Agger; Jens F Dahlerup
Journal:  Inflammopharmacology       Date:  2013-01-23       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.